This study demonstrates that bladder cancer is a tumour with an average hypoxic fraction of around 10% and we have now shown that intrinsic markers of hypoxia, both GLUT1 and CAIX, can be used to predict survival. This evidence concerns the gene CA9 and neoplasm.